Literature DB >> 12829792

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.

Robson A S Santos1, Ana C Simoes e Silva, Christine Maric, Denise M R Silva, Raquel Pillar Machado, Insa de Buhr, Silvia Heringer-Walther, Sergio Veloso B Pinheiro, Myriam Teresa Lopes, Michael Bader, Elizabeth P Mendes, Virgina Soares Lemos, Maria Jose Campagnole-Santos, Heinz-Peter Schultheiss, Robert Speth, Thomas Walther.   

Abstract

The renin-angiotensin system plays a critical role in blood pressure control and body fluid and electrolyte homeostasis. Besides angiotensin (Ang) II, other Ang peptides, such as Ang III [Ang-(2-8)], Ang IV [Ang-(3-8)], and Ang-(1-7) may also have important biological activities. Ang-(1-7) has become an angiotensin of interest in the past few years, because its cardiovascular and baroreflex actions counteract those of Ang II. Unique angiotensin-binding sites specific for this heptapeptide and studies with a selective Ang-(1-7) antagonist indicated the existence of a distinct Ang-(1-7) receptor. We demonstrate that genetic deletion of the G protein-coupled receptor encoded by the Mas protooncogene abolishes the binding of Ang-(1-7) to mouse kidneys. Accordingly, Mas-deficient mice completely lack the antidiuretic action of Ang-(1-7) after an acute water load. Ang-(1-7) binds to Mas-transfected cells and elicits arachidonic acid release. Furthermore, Mas-deficient aortas lose their Ang-(1-7)-induced relaxation response. Collectively, these findings identify Mas as a functional receptor for Ang-(1-7) and provide a clear molecular basis for the physiological actions of this biologically active peptide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829792      PMCID: PMC166216          DOI: 10.1073/pnas.1432869100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Interaction between Mas and the angiotensin AT1 receptor in the amygdala.

Authors:  O Von Bohlen und Halbach; T Walther; M Bader; D Albrecht
Journal:  J Neurophysiol       Date:  2000-04       Impact factor: 2.714

Review 2.  Angiotensin-(1-7): an update.

Authors:  R A Santos; M J Campagnole-Santos; S P Andrade
Journal:  Regul Pept       Date:  2000-07-28

3.  Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7).

Authors:  S Heringer-Walther; T Walther; M C Khosla; R A Santos; M J Campagnole-Santos
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

4.  Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains.

Authors:  D Young; G Waitches; C Birchmeier; O Fasano; M Wigler
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

5.  Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.

Authors:  R D Paula; C V Lima; M C Khosla; R A Santos
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

6.  Molecular structure and expression of rat bradykinin B2 receptor gene. Evidence for alternative splicing.

Authors:  J B Pesquero; C J Lindsey; K Zeh; A C Paiva; D Ganten; M Bader
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

7.  Imprinting of the murine MAS protooncogene is restricted to its antisense RNA.

Authors:  Natalia Alenina; Michael Bader; Thomas Walther
Journal:  Biochem Biophys Res Commun       Date:  2002-01-25       Impact factor: 3.575

8.  An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma.

Authors:  A C Lawrence; G Evin; A Kladis; D J Campbell
Journal:  J Hypertens       Date:  1990-08       Impact factor: 4.844

9.  Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells.

Authors:  M M Muthalif; I F Benter; M R Uddin; J L Harper; K U Malik
Journal:  J Pharmacol Exp Ther       Date:  1998-01       Impact factor: 4.030

Review 10.  Angiotensin II receptor antagonists.

Authors:  M Burnier; H R Brunner
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

View more
  543 in total

Review 1.  Role of ACE2 in diastolic and systolic heart failure.

Authors:  Wang Wang; Sreedhar Bodiga; Subhash K Das; Jennifer Lo; Vaibhav Patel; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 2.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 3.  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.

Authors:  Ana Cristina Simões E Silva; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-09-23       Impact factor: 3.714

4.  Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.

Authors:  Tanya M Gwathmey; Brian M Westwood; Nancy T Pirro; Lijun Tang; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

Review 5.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

Review 6.  An evolving story of angiotensin-II-forming pathways in rodents and humans.

Authors:  Carlos Maria Ferrario; Sarfaraz Ahmad; Sayaka Nagata; Stephen W Simington; Jasmina Varagic; Neal Kon; Louis Joseph Dell'italia
Journal:  Clin Sci (Lond)       Date:  2014-04       Impact factor: 6.124

7.  Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.

Authors:  Chao Fang; Evi Stavrou; Alec A Schmaier; Nadja Grobe; Mariana Morris; Andrew Chen; Marvin T Nieman; Gregory N Adams; Gretchen LaRusch; Yihua Zhou; Matthew L Bilodeau; Fakhri Mahdi; Mark Warnock; Alvin H Schmaier
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

8.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.

Authors:  Neha Singh; Shrinidh Joshi; Lirong Guo; Matthew B Baker; Yan Li; Ronald K Castellano; Mohan K Raizada; Yagna P R Jarajapu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 10.  Molecular evidence of tissue renin-angiotensin systems: a focus on the brain.

Authors:  Koji Sakai; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.